Rejuveron CEO Confident About Longevity Biotech Prospects In Troubled Economy

 
• By Marion Webb

Swiss-based Rejuveron’s diversified platform of longevity biotechs addresses key hallmarks of aging, with the goal of helping people to age better and live longer with reduced burden of age-related diseases. CEO Matthias Steger discusses the firm’s vision and the road ahead.    

Aging is a growing business • Source: Shutterstock

More from Growth

More from In Vivo